Biblio

Author Title [ Type(Desc)] Year
Filters: First Letter Of Title is G  [Clear All Filters]
Journal Article
C Fries A, Lawson SD, Wang LC, Slaughter KV, Vemula PK, Dhayani A, Joshi N, Karp JM, Rickard RF, Gorantla VS, et al. Graft-implanted, enzyme responsive, tacrolimus-eluting hydrogel enables long-term survival of orthotopic porcine limb vascularized composite allografts: A proof of concept study. PLoS One. 2019;14(1):e0210914.
Bernardo MP, Rodrigues BC, Sechi A, Mattoso LHc. Grafting of maleic anhydride on poly(lactic acid)/hydroxyapatite composites augments their ability to support osteogenic differentiation of human mesenchymal stem cells. J Biomater Appl. 2022:8853282221147422.
Durço DFPA, Pestana FM, Oliveira JT, Ramalho BDos S, Souza LM, Cardoso FS, da Silva ICT, Marques SA, Domingues RC, Pereira CC, et al. Grafts of human adipose-derived stem cells into a biodegradable poly (acid lactic) conduit enhances sciatic nerve regeneration. Brain Res. 2020:147026.
Brothers L, Malhotra J, Andrews C, Smith SR. Graft-Versus-Host Disease: an Update on Functional Implications and Rehabilitation Interventions. Curr Oncol Rep. 2023.
Leidens N, Ballardin BSoldatelli, Leal GAndré, de Araújo AMagno Mede, Sessenta-Junior CFreire, Torres-Pereira CCarvalho, Schussel JLucena. Graft-versus-host disease and herpes simplex virus oral injuries in onco-hematological patient: Case report. Spec Care Dentist. 2021.
Oechsler S, Gagelmann N, Wolschke C, Janson D, Badbaran A, Klyuchnikov E, Massoud R, Rathje K, Richter J, Schäfersküpper M, et al. Graft-versus-host disease and impact on relapse in myelofibrosis undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant. 2024.
Laste LDhara Dall, Schmidt P, Moreira GAraujo, Silva JHorsth, Abagge KTaniguchi. Graft-versus-host disease and other cutaneous manifestations in pediatric patients transplanted for Fanconi anemia. Rev Paul Pediatr. 2023;41:e2022059.
Devillier R, Eikema D-J, Dufour C, Aljurf M, Wu D, Maschan A, Kulagin A, Halkes CJM, Collin M, Snowden J, et al. Graft-versus-host disease and relapse/rejection-free survival after allogeneic transplantation for idiopathic severe aplastic anemia: a comprehensive analysis from the SAAWP of the EBMT. Haematologica. 2023.
Park S-S, Jeon Y-W, Min GJune, Park S, Yahng S-A, Yoon J-H, Shin S-H, Lee S-E, Cho B-S, Eom K-S, et al. Graft-versus-host disease free, relapse-free survival after allogeneic stem cell transplantation for myelodysplastic syndrome. Biol Blood Marrow Transplant. 2018.
Winstead M, Hill M, Amin Z, Lugt MVander, Chen X, Szabolcs P. Graft-versus-host disease is associated with skewed γδ T-cell clonality after umbilical cord blood transplantation in children with nonmalignant diseases. Cytotherapy. 2023.
Sacirbegovic F, Günther M, Greco A, Zhao D, Wang X, Zhou M, Rosenberger S, Oberbarnscheidt MH, Held W, McNiff J, et al. Graft-versus-host disease is locally maintained in target tissues by resident progenitor-like T cells. Immunity. 2023.
Mathew NR, Vinnakota JM, Apostolova P, Erny D, Hamarsheh S'a, Andrieux G, Kim J-S, Hanke K, Goldmann T, Chappell-Maor L, et al. Graft-versus-host disease of the CNS is mediated by TNF upregulation in microglia. J Clin Invest. 2019.
Koratala A, Segal MS, Farhadfar N, Zeng X. Graft-versus-host disease of the kidney. Hematol Oncol Stem Cell Ther. 2019.
Ziakas PD, Zervou FN, Zacharioudakis IM, Mylonakis E. Graft-Versus-Host Disease Prophylaxis after Transplantation: A Network Meta-Analysis. PLoS One. 2014;9(12):e114735.
Moiseev IS, Pirogova OV, Alyanski AL, Babenko EV, Gindina TL, Darskaya EI, Slesarchuk OA, Bondarenko SN, Afanasyev BV. Graft-versus-host disease prophylaxis in unrelated peripheral blood stem cell transplantation with post-transplantation cyclophosphamide, tacrolimus and mycophenolate mofetil. Biol Blood Marrow Transplant. 2016.
Shiratori S, Kurata M, Sugita J, Ota S, Kasahara S, Ishikawa J, Imada K, Onishi Y, Ishiyama K, Ashida T, et al. Graft-versus-host disease prophylaxis using low-dose antithymocyte globulin in peripheral blood stem cell transplantation - A matched-pair analysis. Transplant Cell Ther. 2021.
Schirico MLo, Passera R, Gill J, Dellacasa C, Dogliotti I, Giaccone L, Zompi S, Busca A. Graft-Versus-Host Disease Prophylaxis with Antithymocyte Globulin in Patients Receiving Stem Cell Transplantation from Unrelated Donors: An Observational Retrospective Single-Center Study. Cancers (Basel). 2023;15(10).
Moiseeev IS, Bondarenko SN, Morozova EV, Vlasova YYu, Dotsenko AA, Epifanovskaya OS, Babenko EV, Botina AV, Baykov VV, Surkova EA, et al. Graft-versus-host disease prophylaxis with posttransplantation bendamustine (PTB) in patients with refractory acute leukemia: a dose-ranging study: Category of manuscript: Regular Manuscript. Transplant Cell Ther. 2021.
Nagler A, Labopin M, Dholaria B, Wu D, Choi G, Aljurf M, Ciceri F, Gedde-Dahl T, Meijer E, Niittyvuopio R, et al. Graft-Versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor Transplantation. Transplant Cell Ther. 2021.
Dertschnig S, Evans P, Sousa PSantos E, Manzo T, Ferrer IR, Stauss HJ, Bennett CL, Chakraverty R. Graft-versus-host disease reduces lymph node display of tissue-restricted self-antigens and promotes autoimmunity. J Clin Invest. 2020.
Paviglianiti A, Ngoya M, Peña M, Boumendil A, Gulbas Z, Ciceri F, Bonifazi F, Russo D, Fegueux N, Stölzel F, et al. Graft-versus-host-disease prophylaxis with ATG or PTCY in patients with lymphoproliferative disorders undergoing reduced intensity conditioning regimen HCT from one antigen mismatched unrelated donor. Bone Marrow Transplant. 2024.
Stadler M, Hambach L, Dammann E, Diedrich H, Kamal H, Hamwi I, Schultze-Florey C, Varvenne M, Ehrlich S, Buchholz S, et al. The graft-versus-leukemia effect of prophylactic donor lymphocyte infusions after allogeneic stem cell transplantation is equally effective in relapse prevention but safer compared to spontaneous graft-versus-host disease. Ann Hematol. 2023.
Ranjbaryan M, Calvani J, Louveau B, Cuccuini W, Battesti G, Bozonnat A, Moins-Teisserenc H, Michonneau D, Bagot M, Ram-Wolff C, et al. Graft-versus-lymphoma effect in skin after allogeneic hematopoietic stem cell transplantation for Sézary syndrome. Eur J Dermatol. 2023;33(4):439-440.
Barisic S, Childs RW. Graft-Versus-Solid-Tumor Effect: From Hematopoietic Stem Cell Transplantation to Adoptive Cell Therapies. Stem Cells. 2022.
Farris JC, Pifer PM, Zheng L, Gottlieb E, Denvir J, Frisch SM. Grainyhead-like 2 Reverses the Metabolic Changes Induced by the Oncogenic Epithelial-mesenchymal Transition: Effects on Anoikis. Mol Cancer Res. 2016.

Pages